Anzeige
Mehr »
Freitag, 24.10.2025 - Börsentäglich über 12.000 News
Gold über 4.000 US-Dollar - Canary Gold startet Multi-Front-Exploration in Brasiliens neuem Gold-Hotspot
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 936853 | ISIN: US28176E1082 | Ticker-Symbol: EWL
Tradegate
24.10.25 | 11:42
66,20 Euro
+0,46 % +0,30
Branche
Pharma
Aktienmarkt
S&P 500
1-Jahres-Chart
EDWARDS LIFESCIENCES CORPORATION Chart 1 Jahr
5-Tage-Chart
EDWARDS LIFESCIENCES CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
66,0766,7112:07
66,1366,7812:04

Aktuelle News zur EDWARDS LIFESCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiPiper Sandler Maintains Overweight on Edwards Lifesciences (EW) Ahead of PARTNER 3 7-Year Results6
17.10.Robust TAVR Growth to Drive Edwards Lifesciences' Q3 Earnings17
EDWARDS LIFESCIENCES Aktie jetzt für 0€ handeln
08.10.Edwards Lifesciences slips as Oppenheimer downgrades on upcoming data10
08.10.Edwards Lifesciences stock downgraded by Oppenheimer on structural concerns4
08.10.Edwards Lifesciences: Oppenheimer stuft Aktie wegen struktureller Bedenken herab18
07.10.Edwards Lifesciences upgraded at Evercore on upcoming 'topline inflection'3
07.10.Edwards Lifesciences stock maintains Overweight rating ahead of PARTNER 3 data4
07.10.Edwards Lifesciences stock upgraded by Evercore ISI on reduced competition9
06.10.Here's What to Expect From Edwards Lifesciences' Next Earnings Report8
22.09.Analyst Expectations For Edwards Lifesciences' Future14
22.09.Edwards Lifesciences price target lowered to $85 by Stifel on TAVR data concerns6
22.09.Stifel senkt Kursziel für Edwards Lifesciences wegen Sorgen um TAVR-Daten auf 85 US-Dollar20
19.09.Edwards Lifesciences Corporation (EW): A Bull Case Theory8
02.09.Leerink Partners Lifts Edwards Lifesciences (EW) Price Target Amid Buybacks Focus21
02.09.Edwards Lifesciences Stock: Is EW Outperforming the Healthcare Sector?6
29.08.Edwards Lifesciences Corporation: Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care396Edwards Lifesciences (NYSE: EW) welcomes the updated ESC/EACTS guidelines for valvular heart disease, which establish a simplified care pathway for all severe aortic stenosis (AS) patients, regardless...
► Artikel lesen
25.08.Pulnovo Medical appoints Edwards Lifesciences veteran as CMO3
20.08.Leerink Partners raises Edwards Lifesciences stock price target on share buyback12
19.08.Edwards Lifesciences launches $500M accelerated share buyback11
19.08.Edwards Lifesciences Corp - 8-K, Current Report2
Weiter >>
86 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1